DFM Funding Monitor
EU dual-use research funding — who's getting it
Horizon Europe dual-use & security-relevant research grants — EC contribution, coordinator and beneficiaries.
Research grants
2657
Updated
2026-07-04
About the data
Source: CORDIS (official EU open data), Horizon Europe civil R&I — the dual-use / security-relevant subset (Cluster 3 Civil Security, defence-relevant keywords, plus EIC deep-tech and space). EDF military R&D is a separate instrument and is not included. Monetary figures are the EC contribution in EUR as published by the Commission.
Contract-award winners → · Awards → · Open tenders →
| Project | Coordinator | Programme | EC contribution | Benef. | CORDIS |
|---|---|---|---|---|---|
| a Quasi Coherent Receiver Optical Sub-Assembly technology for imbroad qc-rosa · 2023-08-01–2025-07-31 |
BIFROST COMMUNICATIONS APS | HORIZON-EIC-2023-ACCELERATOR-01 | €2,498,267 | 1 | CORDIS → |
| Quantum technology components for space communicationbroad QuTechSpace · 2024-01-01–2026-10-31 |
QUANTUM TECHNOLOGY LABORATORIES GMBH | HORIZON-CL4-2023-SPACE-01 | €2,498,261 | 9 | CORDIS → |
| Transforming Insurance Communication with DIALOGIC: AI-Driven Clbroad DIALOGIC · 2026-04-01–2028-03-31 |
INDEEP ARTIFICIAL INTELLIGENCE SL | HORIZON-EIC-2025-TRANSITIONOPEN | €2,498,250 | 1 | CORDIS → |
| Chronic Deep-Brain Micro-Endoscopy in Behaving Animal Models: Adbroad NEUROGATE · 2025-05-01–2028-04-30 |
LEIBNIZ-INSTITUT FUER PHOTONISCHE TECHNOLOGIEN E.V. | HORIZON-EIC-2024-TRANSITION-01 | €2,498,227 | 4 | CORDIS → |
| Leveraging CRISPR-Cas for fast and accurate point-of-care diagnobroad SCOPE · 2024-03-01–2026-02-28 |
SCOPE BIOSCIENCES B.V. | HORIZON-EIC-2023-TRANSITION-01 | €2,498,125 | 1 | CORDIS → |
| Pioneering automated building digitisation with Lumoview for empbroad LumoGen1 · 2024-04-01–2026-12-31 |
LUMOVIEW BUILDING ANALYTICS GMBH | HORIZON-EIC-2023-ACCELERATOR-01 | €2,498,125 | 1 | CORDIS → |
| Accelerating breakthrough Innovation to monitor, control and redbroad AIM · 2024-11-01–2026-10-31 |
ABSOLUT SENSING | HORIZON-EIC-2024-ACCELERATOR-02 | €2,498,125 | 1 | CORDIS → |
| First time ultra-sensitive and simultaneous quantification of prbroad PICO-NGS · 2023-08-01–2025-07-31 |
ACTOME GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,498,125 | 1 | CORDIS → |
| Anticancer approach based on the Metabolic Disruption of Cancer broad MEDiCS · 2025-05-01–2028-04-30 |
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA | HORIZON-EIC-2024-TRANSITION-01 | €2,498,016 | 5 | CORDIS → |
| C-CLAW - The revolutionary Non-intrusive mechanical Fastener thabroad C_CLAW_C_HAWK · 2022-03-01–2024-10-31 |
COLD PAD | HORIZON-EIC-2021-ACCELERATOROPEN-01 | €2,498,015 | 1 | CORDIS → |
| Best-in-class canceR dIaGnostic cHip for patient sTratification.broad BRIGHT · 2022-08-01–2025-12-31 |
RUBYNANOMED LDA | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,497,881 | 1 | CORDIS → |
| automated in-line separatioN and dEtection of eXtracellular vesibroad NEXUS · 2022-06-01–2025-05-31 |
CONSIGLIO NAZIONALE DELLE RICERCHE | HORIZON-EIC-2021-TRANSITIONOPEN-01 | €2,497,750 | 5 | CORDIS → |
| Superhydrophobic membranes for clean water productionbroad SuperClean · 2023-01-01–2026-06-30 |
NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""" | HORIZON-EIC-2022-TRANSITION-01 | €2,497,750 | 6 | CORDIS → |
| PEN photoporation for the genetic engineering of therapeutic mesbroad Penphomet · 2024-03-01–2027-02-28 |
TRINCE | HORIZON-EIC-2023-TRANSITION-01 | €2,497,711 | 3 | CORDIS → |
| A novel and accurate emotion recognition system for real-time anbroad ADAPTE · 2023-11-01–2026-04-30 |
CEPHALGO | HORIZON-EIC-2023-ACCELERATOR-01 | €2,497,708 | 1 | CORDIS → |
| Reversibly operating fuels cells for clean energy and long-term broad Reverion · 2023-02-01–2025-04-30 |
REVERION GMBH | HORIZON-EIC-2022-ACCELERATOR-01 | €2,497,688 | 1 | CORDIS → |
| Releaf Paper - breakthrough technology for sustainable productiobroad Releaf Paper - sustainable leaves-based paper · 2023-05-01–2025-04-30 |
RELEAF PAPER FRANCE SAS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,497,618 | 1 | CORDIS → |
| Automatic vein wall disruption, triggering the body’s natural cebroad EnVena · 2022-10-01–2024-09-30 |
INVERA MEDICAL LIMITED | HORIZON-EIC-2022-ACCELERATOR-01 | €2,497,614 | 1 | CORDIS → |
| Rebuilding our world with new carbon elements that turn buildingbroad Elementic · 2025-05-01–2027-04-30 |
Fifth Innovation Oy | HORIZON-EIC-2024-ACCELERATOR-02 | €2,497,596 | 1 | CORDIS → |
| Disruptive and high accuracy test for early colorectal cancer debroad PreveCol · 2022-08-01–2025-03-31 |
ADVANCED MARKER DISCOVERY SL | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,497,568 | 1 | CORDIS → |
| Next generation, off-the-shelf, non fratricide-directed, CAR immbroad CARxALL · 2023-04-01–2026-07-31 |
ONECHAIN IMMUNOTHERAPEUTICS S.L. | HORIZON-EIC-2022-TRANSITION-01 | €2,497,500 | 3 | CORDIS → |
| Making Superconducting power grids a feasible solution for Europbroad SUBRACABLE · 2023-09-01–2025-08-31 |
SUBRA A/S | HORIZON-EIC-2023-ACCELERATOR-01 | €2,497,492 | 1 | CORDIS → |
| Bypassing open heart surgery with Excimer Laser Assisted Non Occbroad ELANA® · 2022-10-01–2025-09-30 |
AMT MEDICAL RESEARCH BV | HORIZON-EIC-2022-ACCELERATOR-01 | €2,497,469 | 2 | CORDIS → |
| First fast and automated (<5 min) AI-based inspection to increasbroad Twinspect · 2023-12-01–2025-11-30 |
TWINSITY GMBH | HORIZON-EIC-2023-ACCELERATOR-01 | €2,497,425 | 1 | CORDIS → |
| De Novo Ossification using human engineered cartilage as cell-frbroad DENOVOSS · 2026-06-01–2029-05-31 |
LUNDS UNIVERSITET | HORIZON-EIC-2025-TRANSITIONOPEN | €2,497,375 | 4 | CORDIS → |
| 3D JETPEP - REVOLUTIONIZING HIGH-VALUE MANUFACTURING WITH MULTI-broad 3D JETPEP Finishing · 2025-11-01–2027-10-31 |
plasmotion GmbH | HORIZON-EIC-2025-ACCELERATOR-02 | €2,497,326 | 1 | CORDIS → |
| Fail-operational safety – making autonomous vehicles a realitybroad TrueSbW · 2023-05-01–2025-04-30 |
CHASSIS AUTONOMY SBA AB | HORIZON-EIC-2022-ACCELERATOR-01 | €2,497,305 | 1 | CORDIS → |
| Development of an innovative GPM for the ZEPHYR microlauncherbroad ZEPHYR · 2024-12-01–2026-11-30 |
LATITUDE | HORIZON-EIC-2024-ACCELERATOR-02 | €2,497,250 | 1 | CORDIS → |
| Veridi: AI-Powered Soil Biodiversity Analysis and Monitoringbroad VERIDI · 2025-06-01–2027-05-31 |
Veridi Technologies BV | HORIZON-EIC-2024-ACCELERATOR-02 | €2,497,250 | 1 | CORDIS → |
| Lignocellulosic oil: novel biofuel platform for maritime transpobroad SEAFARER · 2022-11-01–2025-10-31 |
KVASIR TECHNOLOGIES APS | HORIZON-EIC-2022-ACCELERATOR-01 | €2,497,250 | 1 | CORDIS → |
| Sustainable Seafood Productionbroad Bluegrove Welfare Shield · 2022-07-01–2024-12-31 |
CAGEEYE AS | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,497,241 | 1 | CORDIS → |
| Artificial Right-Heart without External Power from Bench-to-Bedsbroad HeartWise · 2025-06-01–2028-05-31 |
KOC UNIVERSITY | HORIZON-EIC-2024-TRANSITION-01 | €2,497,090 | 3 | CORDIS → |
| Carbon-Negative Construction Wallboardbroad Breathaboard · 2026-04-01–2028-03-31 |
Adaptavate Limited | HORIZON-EIC-2025-ACCELERATOR-02 | €2,496,988 | 1 | CORDIS → |
| Smart Microrobotic Biopsy: A Leap Forward in Brain Disease Diagnbroad SmartMicroBiopsy · 2025-07-01–2027-06-30 |
Robeaute | HORIZON-EIC-2024-ACCELERATOR-02 | €2,496,931 | 1 | CORDIS → |
| ComfyCell: Novel Bionic Bioreactor for Industrial Stem and Immunbroad ComfyCell · 2025-09-01–2027-08-31 |
BIOTHRUST GMBH | HORIZON-EIC-2024-ACCELERATOR-02 | €2,496,897 | 1 | CORDIS → |
| Personalised Health cognitive assistance for RehAbilitation Systbroad PHRASE · 2022-04-01–2025-07-31 |
EODYNE SYSTEMS SL | HORIZON-EIC-2021-TRANSITION-CHALLENGES-01 | €2,496,674 | 5 | CORDIS → |
| 3D Printed Micro-Optics to the Marketbroad 3DPRINTOPTIXMARKET · 2023-06-01–2026-05-31 |
PRINTOPTIX GMBH | HORIZON-EIC-2022-TRANSITION-01 | €2,496,603 | 2 | CORDIS → |
| Quantum software platform for multiphysics simulationsbroad Qu&Co-Flow · 2022-12-01–2024-11-30 |
Pasqal Netherlands BV | HORIZON-EIC-2022-ACCELERATOR-01 | €2,496,599 | 1 | CORDIS → |
| Reducing natural gas needs and carbon emissions in industrial usbroad herc accelerating industrial co2 neutrality · 2023-02-01–2025-07-31 |
EFENCO OU | HORIZON-EIC-2022-ACCELERATOR-01 | €2,496,592 | 1 | CORDIS → |
| Non-Destructive Fully Automated Subsurface Metrology and Inspectbroad AUDIRA · 2024-11-01–2026-04-30 |
NEARFIELD INSTRUMENTS B.V. | HORIZON-EIC-2024-ACCELERATOR-02 | €2,496,499 | 1 | CORDIS → |
| Next generation gene writing platform to cure genetic and oncolobroad FiCAT · 2024-12-01–2026-11-30 |
INTEGRA THERAPEUTICS S.L. | HORIZON-EIC-2024-ACCELERATOR-02 | €2,496,375 | 1 | CORDIS → |
| Next Generation Software Supply Chain Securitybroad COANA · 2025-06-01–2027-05-31 |
COANA APS | HORIZON-EIC-2024-TRANSITION-01 | €2,496,250 | 1 | CORDIS → |
| A pioneer clinical trial management system to automatically collbroad YL System · 2022-09-01–2025-02-28 |
YONALINK LTD | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,496,243 | 1 | CORDIS → |
| Accelerating Datacentre performance through Memory Chips to effibroad ENERGIA/PIM · 2022-03-01–2024-02-29 |
SAS UPMEM | HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 | €2,496,230 | 1 | CORDIS → |
| IOO: a novel assay to predict patient response to immune checkpobroad IOO - Improving IO · 2024-08-01–2026-12-31 |
FASTBASE SOLUTIONS SOCIEDAD LIMITADA | HORIZON-EIC-2023-ACCELERATOR-01 | €2,496,112 | 1 | CORDIS → |
| Building the world’s largest digital hospital for neurological cbroad VR4NEURO · 2022-11-01–2025-03-31 |
PEILI VISION OY | HORIZON-EIC-2022-ACCELERATOR-01 | €2,496,112 | 1 | CORDIS → |
| IDEFIX Multiorgan toxicity and efficacy test platformbroad IDEFIX · 2022-11-01–2024-08-31 |
CHERRY BIOTECH | HORIZON-EIC-2022-TRANSITION-01 | €2,496,073 | 1 | CORDIS → |
| A fungi-based biotechnological platform for competitive multi-stbroad WASTE2WEALTH · 2025-06-01–2027-05-31 |
NOVOBIOM | HORIZON-EIC-2024-ACCELERATOR-02 | €2,496,055 | 1 | CORDIS → |
| Femtosecond laser writing for photonic quantum processorsbroad FUTURE · 2023-11-01–2026-01-31 |
EPHOS SRL | HORIZON-EIC-2023-TRANSITION-01 | €2,495,969 | 1 | CORDIS → |
| Smart Immune ProTcell: first-in-class allogeneic thymus empowerebroad Smart ProTcell · 2023-06-01–2025-11-30 |
SMART IMMUNE | HORIZON-EIC-2023-ACCELERATOR-01 | €2,495,938 | 1 | CORDIS → |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.